Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Digital health trial tests home monitoring for seniors in taiwan

NCT ID NCT07238257

Disease control Sponsor: Chang Gung Memorial Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This completed trial in Taiwan tested whether a digital health program helps middle-aged and older adults manage conditions like high blood pressure, diabetes, and high cholesterol. 199 participants from four communities used smart devices to measure their health data at home, which doctors reviewed monthly to give personalized advice. The study lasted 6 months and looked at changes in blood sugar, blood pressure, uric acid, and weight.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Digital health program with smart devices (blood pressure monitor, glucose meter, uric acid meter, cholesterol meter, ECG device) and monthly physician consultations
What this could lead to
If successful, this could show that simple home monitoring with doctor support helps older adults better manage chronic conditions like high blood pressure and diabetes.
What could go wrong
This is a small, completed trial in Taiwan, so results may not apply to other populations. The intervention requires participants to use smart devices, which may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

199 people

The number who actually took part.

Started

Dec 2023

Finished

Dec 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 50 years and older * Resided in the community for at least 6 months * Able and willing to provide written informed consent Exclusion Criteria: * Severe cognitive impairment * Terminal illness * Inability to operate basic digital devices (e.g., smartphone, health monitoring device) * Declined to provide informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Health promotion are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Hypercholesterolemia hyperlipidemia hypertensive disorder Hyperuricemia insomnia Overweight type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Health promotion Hypercholesterolemia and hyperlipidemia Hypertension (HTN) Hyperuricemia Overweight (bmi > 25) Sleep quality Type 2 diabetes mellitus (T2DM)

Contacts and locations

Locations

  • Chang Gung Memorial Hospital, Linkou Branch

    Taoyuan, Taoyuan, 333, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.